Role of brain dopamine in centrally evoked angiotensin ii responses in conscious rats

Hiroshi Kawabe, K. Bridget Brosnihan, Debra I. Diz, Carlos M. Ferrario

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Because intracerebroventricular (i.c.v.) injection of angiotensin II enhances the activity of brain dopaminergic neurons, the possible role of the brain dopamine neuronal system as a mediator of the pressor, dipsogenic, and neurohormonal effects of centrally administered angiotensin II was examined in this study. In conscious male Sprague-Dawley rats, injections of angiotensin II (125 ng i.c.v.) caused a significant increase in mean arterial pressure (19 ± 1 mm Hg), which was not changed by i.c.v. pretreatment with a subpressor dose of either dopamine (16 ± 1 mm Hg) or the dopamine antagonist metoclopramide (21 ± 1 mm Hg). However, angiotensin II-induced drinking (11.3 ± 0.4 ml/30 min) was partially inhibited by i.c.v. pretreatment with metoclopramide (7.4 ±1.0 ml/30 min, p < 0.01) but not affected by i.c.v. dopamine pretreatment. Intraventricular injections of angiotensin II caused a sixfold increase in plasma arginine vasopressin (10.9 ±1.3 pg/ml vs 1.7 ± 0.7 pg/ml in control rats, p < 0.01), which was enhanced by metoclopramide (17.6 ± 2.3 pg/ml, p < 0.01). Dopamine pretreatment had no significant effect on this increase in plasma arginine vasopressin (7.1 ±1.1 pg/ml) produced by angiotensin II, Angiotensin II-induced suppression of plasma renin activity from 14.7 ± 1.2 to 6.8 ± 1.6 ng/ml/hr was not affected by prior i.c.v. administration of either dopamine or metoclopramide. Central injection of dopamine or metoclopramide alone had no effect on plasma arginine vasopressin or plasma renin activity levels, mean arterial pressure, or water intake. Our results suggest that central dopaminergic neurons interact with centrally administered angiotensin II in the regulation of hydromineral balance and neurohypophysial release of arginine vasopressin but not in the regulation of blood pressure or plasma renin activity.

Original languageEnglish
Pages (from-to)84-89
Number of pages6
JournalHypertension
Volume8
Issue number4
Publication statusPublished - 1986
Externally publishedYes

Fingerprint

Angiotensins
Angiotensin II
Dopamine
Metoclopramide
Arginine Vasopressin
Brain
Renin
Dopaminergic Neurons
Injections
Drinking
Arterial Pressure
Intraventricular Injections
Dopamine Antagonists
Sprague Dawley Rats
Blood Pressure

Keywords

  • Angiotensin II drinking
  • Blood pressure
  • Cerebrospinal fluid
  • Dopamine
  • Metoclopramide
  • Plasma renin activity
  • Vasopressin

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Kawabe, H., Bridget Brosnihan, K., Diz, D. I., & Ferrario, C. M. (1986). Role of brain dopamine in centrally evoked angiotensin ii responses in conscious rats. Hypertension, 8(4), 84-89.

Role of brain dopamine in centrally evoked angiotensin ii responses in conscious rats. / Kawabe, Hiroshi; Bridget Brosnihan, K.; Diz, Debra I.; Ferrario, Carlos M.

In: Hypertension, Vol. 8, No. 4, 1986, p. 84-89.

Research output: Contribution to journalArticle

Kawabe, H, Bridget Brosnihan, K, Diz, DI & Ferrario, CM 1986, 'Role of brain dopamine in centrally evoked angiotensin ii responses in conscious rats', Hypertension, vol. 8, no. 4, pp. 84-89.
Kawabe H, Bridget Brosnihan K, Diz DI, Ferrario CM. Role of brain dopamine in centrally evoked angiotensin ii responses in conscious rats. Hypertension. 1986;8(4):84-89.
Kawabe, Hiroshi ; Bridget Brosnihan, K. ; Diz, Debra I. ; Ferrario, Carlos M. / Role of brain dopamine in centrally evoked angiotensin ii responses in conscious rats. In: Hypertension. 1986 ; Vol. 8, No. 4. pp. 84-89.
@article{a5db282d63424d768e65f5539c0ca47b,
title = "Role of brain dopamine in centrally evoked angiotensin ii responses in conscious rats",
abstract = "Because intracerebroventricular (i.c.v.) injection of angiotensin II enhances the activity of brain dopaminergic neurons, the possible role of the brain dopamine neuronal system as a mediator of the pressor, dipsogenic, and neurohormonal effects of centrally administered angiotensin II was examined in this study. In conscious male Sprague-Dawley rats, injections of angiotensin II (125 ng i.c.v.) caused a significant increase in mean arterial pressure (19 ± 1 mm Hg), which was not changed by i.c.v. pretreatment with a subpressor dose of either dopamine (16 ± 1 mm Hg) or the dopamine antagonist metoclopramide (21 ± 1 mm Hg). However, angiotensin II-induced drinking (11.3 ± 0.4 ml/30 min) was partially inhibited by i.c.v. pretreatment with metoclopramide (7.4 ±1.0 ml/30 min, p < 0.01) but not affected by i.c.v. dopamine pretreatment. Intraventricular injections of angiotensin II caused a sixfold increase in plasma arginine vasopressin (10.9 ±1.3 pg/ml vs 1.7 ± 0.7 pg/ml in control rats, p < 0.01), which was enhanced by metoclopramide (17.6 ± 2.3 pg/ml, p < 0.01). Dopamine pretreatment had no significant effect on this increase in plasma arginine vasopressin (7.1 ±1.1 pg/ml) produced by angiotensin II, Angiotensin II-induced suppression of plasma renin activity from 14.7 ± 1.2 to 6.8 ± 1.6 ng/ml/hr was not affected by prior i.c.v. administration of either dopamine or metoclopramide. Central injection of dopamine or metoclopramide alone had no effect on plasma arginine vasopressin or plasma renin activity levels, mean arterial pressure, or water intake. Our results suggest that central dopaminergic neurons interact with centrally administered angiotensin II in the regulation of hydromineral balance and neurohypophysial release of arginine vasopressin but not in the regulation of blood pressure or plasma renin activity.",
keywords = "Angiotensin II drinking, Blood pressure, Cerebrospinal fluid, Dopamine, Metoclopramide, Plasma renin activity, Vasopressin",
author = "Hiroshi Kawabe and {Bridget Brosnihan}, K. and Diz, {Debra I.} and Ferrario, {Carlos M.}",
year = "1986",
language = "English",
volume = "8",
pages = "84--89",
journal = "Hypertension",
issn = "0194-911X",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Role of brain dopamine in centrally evoked angiotensin ii responses in conscious rats

AU - Kawabe, Hiroshi

AU - Bridget Brosnihan, K.

AU - Diz, Debra I.

AU - Ferrario, Carlos M.

PY - 1986

Y1 - 1986

N2 - Because intracerebroventricular (i.c.v.) injection of angiotensin II enhances the activity of brain dopaminergic neurons, the possible role of the brain dopamine neuronal system as a mediator of the pressor, dipsogenic, and neurohormonal effects of centrally administered angiotensin II was examined in this study. In conscious male Sprague-Dawley rats, injections of angiotensin II (125 ng i.c.v.) caused a significant increase in mean arterial pressure (19 ± 1 mm Hg), which was not changed by i.c.v. pretreatment with a subpressor dose of either dopamine (16 ± 1 mm Hg) or the dopamine antagonist metoclopramide (21 ± 1 mm Hg). However, angiotensin II-induced drinking (11.3 ± 0.4 ml/30 min) was partially inhibited by i.c.v. pretreatment with metoclopramide (7.4 ±1.0 ml/30 min, p < 0.01) but not affected by i.c.v. dopamine pretreatment. Intraventricular injections of angiotensin II caused a sixfold increase in plasma arginine vasopressin (10.9 ±1.3 pg/ml vs 1.7 ± 0.7 pg/ml in control rats, p < 0.01), which was enhanced by metoclopramide (17.6 ± 2.3 pg/ml, p < 0.01). Dopamine pretreatment had no significant effect on this increase in plasma arginine vasopressin (7.1 ±1.1 pg/ml) produced by angiotensin II, Angiotensin II-induced suppression of plasma renin activity from 14.7 ± 1.2 to 6.8 ± 1.6 ng/ml/hr was not affected by prior i.c.v. administration of either dopamine or metoclopramide. Central injection of dopamine or metoclopramide alone had no effect on plasma arginine vasopressin or plasma renin activity levels, mean arterial pressure, or water intake. Our results suggest that central dopaminergic neurons interact with centrally administered angiotensin II in the regulation of hydromineral balance and neurohypophysial release of arginine vasopressin but not in the regulation of blood pressure or plasma renin activity.

AB - Because intracerebroventricular (i.c.v.) injection of angiotensin II enhances the activity of brain dopaminergic neurons, the possible role of the brain dopamine neuronal system as a mediator of the pressor, dipsogenic, and neurohormonal effects of centrally administered angiotensin II was examined in this study. In conscious male Sprague-Dawley rats, injections of angiotensin II (125 ng i.c.v.) caused a significant increase in mean arterial pressure (19 ± 1 mm Hg), which was not changed by i.c.v. pretreatment with a subpressor dose of either dopamine (16 ± 1 mm Hg) or the dopamine antagonist metoclopramide (21 ± 1 mm Hg). However, angiotensin II-induced drinking (11.3 ± 0.4 ml/30 min) was partially inhibited by i.c.v. pretreatment with metoclopramide (7.4 ±1.0 ml/30 min, p < 0.01) but not affected by i.c.v. dopamine pretreatment. Intraventricular injections of angiotensin II caused a sixfold increase in plasma arginine vasopressin (10.9 ±1.3 pg/ml vs 1.7 ± 0.7 pg/ml in control rats, p < 0.01), which was enhanced by metoclopramide (17.6 ± 2.3 pg/ml, p < 0.01). Dopamine pretreatment had no significant effect on this increase in plasma arginine vasopressin (7.1 ±1.1 pg/ml) produced by angiotensin II, Angiotensin II-induced suppression of plasma renin activity from 14.7 ± 1.2 to 6.8 ± 1.6 ng/ml/hr was not affected by prior i.c.v. administration of either dopamine or metoclopramide. Central injection of dopamine or metoclopramide alone had no effect on plasma arginine vasopressin or plasma renin activity levels, mean arterial pressure, or water intake. Our results suggest that central dopaminergic neurons interact with centrally administered angiotensin II in the regulation of hydromineral balance and neurohypophysial release of arginine vasopressin but not in the regulation of blood pressure or plasma renin activity.

KW - Angiotensin II drinking

KW - Blood pressure

KW - Cerebrospinal fluid

KW - Dopamine

KW - Metoclopramide

KW - Plasma renin activity

KW - Vasopressin

UR - http://www.scopus.com/inward/record.url?scp=0022495125&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022495125&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0022495125

VL - 8

SP - 84

EP - 89

JO - Hypertension

JF - Hypertension

SN - 0194-911X

IS - 4

ER -